The 1 linked reference in paper Article Editorial , Статья Редакционная (2018) “О ВОЗМОЖНОСТЯХ ОСЛАБЛЕНИЯ ИНТЕНСИВНОСТИ АНТИТРОМБОЦИТАРНОЙ ТЕРАПИИ У БОЛЬНЫХ ПОСЛЕ ОСТРОГО КОРОНАРНОГО СИНДРОМА РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ ОБЩЕСТВА СПЕЦИАЛИСТОВ ПО НЕОТЛОЖНОЙ КАРДИОЛОГИИ // ON THE POSSIBILITIES OF ATTENUATION OF ANTIPLATELET THERAPY INTENSITY IN PATIENTS AFTER ACUTE CORONARY SYNDROME. RESOLUTION OF THE PANEL OF EXPERTS OF THE EMERGENCY CARDIOLOGY SOCIETY” / spz:neicon:aterotromboz:y:2018:i:1:p:67-69

  1. Valgimigli M, Bueno H, Byrne RA et al., ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 2017, doi: 10.1093 / eurheartj / ehx419. [Epub ahead of print].